Impact of Tandem Autologous/Non Myeloablative Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Multiple Myeloma Relapsing After a First High Dose Therapy in the Era of Novels Anti-Myeloma Agents

被引：0
|
作者：
Harel, Stephanie [1 ]
Bernard, Sophie
Chevret, Sylvie [2 ]
de Latour, Regis Peffault
Karlin, Lionel [1 ]
Robin, Marie
Ades, Lionel [3 ]
Szalat, Raphael [1 ]
Malphette, Marion [1 ]
Asli, Bouchra [1 ]
Fermand, Jean Paul [1 ]
Arnulf, Bertrand [1 ]
Socie, Gerard
机构：
[1] Hop St Louis, Dept Hematol & Immunol, Paris, France
[2] Univ Paris 07, Hop St Louis, AP HP, Paris, France
[3] Univ Paris 13, Hop Avicenne, AP HP, Dept Hematol, Paris, France
来源：
BLOOD | 2012年 / 120卷 / 21期
关键词：
D O I：
10.1182/blood.V120.21.2035.2035
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2035
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Phase I/II study with bendamustine hydrochloride in patients with multiple myeloma relapsing after high dose therapy and autologous stem cell transplantation
    Knop, S
    Straka, C
    Hebart, H
    Haen, M
    Kanz, L
    Einsele, H
    BLOOD, 2003, 102 (11) : 383B - 383B
  • [22] Stem cell mobilization in multiple myeloma patients relapsing after previous autologous hematopoietic stem cell transplantation: A multicenter report by the Polish Myeloma Study Group
    Drozd-Sokolowska, Joanna
    Waszczuk-Gajda, Anna
    Topczewska, Magdalena
    Manko, Joanna
    Hus, Iwona
    Szmigielska-Kaplon, Anna
    Nowicki, Mateusz
    Grygoruk-Wisniowska, Iwona
    Krawczyk-Kulis, Malgorzata
    Romejko-Jarosinska, Joanna
    Fraczak, Ewa
    Wrobel, Tomasz
    Piatkowska-Jakubas, Beata
    Madry, Krzysztof
    Boguradzki, Piotr
    Krol, Malgorzata
    Koziol, Magdalena
    Hus, Marek
    Kopinska, Anna
    Dmoszynska, Anna
    Basak, Grzegorz Wladyslaw
    Dwilewicz-Trojaczek, Jadwiga
    JOURNAL OF CLINICAL APHERESIS, 2021, 36 (03) : 443 - 453
  • [23] Outcome after autologous and allogeneic stem cell transplantation for patients with multiple myeloma: impact of graft-versus-myeloma effect
    Alyea, E
    Weller, E
    Schlossman, R
    Canning, C
    Mauch, P
    Ng, A
    Fisher, D
    Gribben, J
    Freeman, A
    Parikh, B
    Richardson, P
    Soiffer, R
    Ritz, J
    Anderson, KC
    BONE MARROW TRANSPLANTATION, 2003, 32 (12) : 1145 - 1151
  • [24] Outcome after autologous and allogeneic stem cell transplantation for patients with multiple myeloma: impact of graft-versus-myeloma effect
    E Alyea
    E Weller
    R Schlossman
    C Canning
    P Mauch
    A Ng
    D Fisher
    J Gribben
    A Freeman
    B Parikh
    P Richardson
    R Soiffer
    J Ritz
    K C Anderson
    Bone Marrow Transplantation, 2003, 32 : 1145 - 1151
  • [25] Non-Myeloablative Allogeneic Hematopoietic Cell Transplantation Followed by Bortezomib Maintenance Therapy for High Risk Multiple Myeloma
    Green, Damian J.
    Maloney, David G.
    Storer, Barry E.
    Sandmaier, Brenda M.
    Holmberg, Leona A.
    Martin, Paul J.
    Becker, Pamela S.
    Georges, George E.
    Bouvier, Michelle E.
    Storb, Rainer
    Mielcarek, Marco B.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2017, 23 (03) : S215 - S215
  • [26] Allogeneic transplantation after non-myeloablative conditioning consolidation therapy following high-dose melphalan and autologous stem cell transplantation improve outcome in high-risk multiple myeloma
    Martino, M
    Beltrami, G
    Corsetti, MT
    Penna, G
    Messina, G
    Morabito, F
    Iacopino, P
    Carella, A
    BONE MARROW TRANSPLANTATION, 2004, 33 : S156 - S156
  • [27] Tandem autologous/allogeneic hematopoietic cell transplantation with bortezomib maintenance therapy for high-risk myeloma
    Green, Damian J.
    Maloney, David G.
    Storer, Barry E.
    Sandmaier, Brenda M.
    Holmberg, Leona A.
    Becker, Pamela S.
    Fang, Min
    Martin, Paul J.
    Georges, George E.
    Bouvier, Michelle E.
    Storb, Rainer
    Mielcarek, Marco
    BLOOD ADVANCES, 2017, 1 (24) : 2247 - 2256
  • [28] Chance of clinical disease pattern in patients with multiple myeloma relapsing after allogeneic or autologous stem cell transplantation.
    Rösler, W
    Winkler, J
    Kalden, JR
    Gramatzki, M
    BONE MARROW TRANSPLANTATION, 1999, 23 : S138 - S138
  • [29] Clinical disease pattern changes in patients with multiple myeloma relapsing after allogeneic or autologous stem cell transplantation.
    Rösler, W
    Winkler, J
    Kalden, JR
    Gramatzki, M
    BLOOD, 1998, 92 (10) : 346B - 346B
  • [30] The impact of the new anti-myeloma drugs on outcome of the allogeneic stem cell transplantation with reduced-intensity conditioning in patients with high-risk multiple myeloma
    El Cheikh, J.
    Crocchiolo, R.
    Vazquez, A.
    Stoppa, A. M.
    Furst, S.
    Castagna, L.
    Faucher, C.
    Granata, A.
    Oudin, C.
    De Colella, J. M. Schiano
    Blaise, D.
    BONE MARROW TRANSPLANTATION, 2011, 46 : S255 - S255
12345